Anbesol Baby (benzocaine formulation) Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Anbesol Baby (benzocaine formulation)
A
- Aczone (dapsone topical)
- Adenocaine PF (adenosine / lidocaine / magnesium sulfate)
- adenosine / lidocaine / magnesium sulfate
- AgonEaze (lidocaine / prilocaine topical)
- Alkabel-SR (atropine / hyoscyamine / phenobarbital / scopolamine)
- aminophylline / ephedrine / guaifenesin / phenobarbital
- aminophylline / ephedrine / phenobarbital / potassium iodide
- aminosalicylic acid
- amyl nitrite
- amyl nitrite/sodium nitrite/sodium thiosulfate
- Anestacaine (lidocaine)
- Anodyne LPT (lidocaine / prilocaine topical)
- Antispas (atropine / hyoscyamine / phenobarbital / scopolamine)
- Antispasmodic (atropine / hyoscyamine / phenobarbital / scopolamine)
- Antrocol (atropine / phenobarbital)
- Arakoda (tafenoquine)
- Aralen (chloroquine)
- Aralen Hydrochloride (chloroquine)
- Aralen Phosphate (chloroquine)
- Articadent (articaine / epinephrine)
- articaine / epinephrine
- atropine / hyoscyamine / phenobarbital / scopolamine
- atropine / phenobarbital
- Azo Gantanol (phenazopyridine / sulfamethoxazole)
- Azo Gantrisin (phenazopyridine / sulfisoxazole)
- Azo Urinary Pain Relief (phenazopyridine)
- Azo-Gesic (phenazopyridine)
- Azo-Septic (phenazopyridine)
- Azo-Standard (phenazopyridine)
- Azo-Truxazole (phenazopyridine / sulfisoxazole)
- Azulfidine (sulfasalazine)
- Azulfidine EN-tabs (sulfasalazine)
More about Anbesol Baby (benzocaine formulation) (benzocaine topical)
- Check interactions
- Compare alternatives
- Latest FDA alerts (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: topical anesthetics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.